1. Home
  2. EQ
  3. EQ News

Latest Equillium Inc. (EQ) News on April 3, 2025

Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
EQ

Zacks

2 days ago

Equillium (EQ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Equillium Full Year 2024 Earnings: Beats Expectations
EQ

Simply Wall St.

6 days ago

Equillium Full Year 2024 Earnings: Beats Expectations

EQ

MT Newswires

6 days ago

Leerink Partners Downgrades Equillium to Market Perform From Outperform, Adjusts Price Target to $1 From $3

Equillium pushes for breakthrough status despite missing primary endpoint
EQ

Clinical Trials Arena

6 days ago

Equillium pushes for breakthrough status despite missing primary endpoint

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
EQ

Business Wire

7 days ago

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
EQ

Business Wire

7 days ago

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?
EQ

Zacks

20 days ago

Are Medical Stocks Lagging Aveanna Healthcare (AVAH) This Year?

Here's Why Equillium (EQ) Is a Great 'Buy the Bottom' Stock Now
EQ

Zacks

a month ago

Here's Why Equillium (EQ) Is a Great 'Buy the Bottom' Stock Now

Equillium (EQ) Upgraded to Buy: Here's What You Should Know
EQ

Zacks

2 months ago

Equillium (EQ) Upgraded to Buy: Here's What You Should Know

Equillium (EQ) Shows Fast-paced Momentum But Is Still a Bargain Stock
EQ

Zacks

2 months ago

Equillium (EQ) Shows Fast-paced Momentum But Is Still a Bargain Stock

CuriosityStream And 2 Other Promising Penny Stocks On US Exchange
EQ

Simply Wall St.

2 months ago

CuriosityStream And 2 Other Promising Penny Stocks On US Exchange

Equillium Reports Positive Phase 2 Results for Itolizumab in Ulcerative Colitis, Shares Surge
EQ

GuruFocus.com

2 months ago

Equillium Reports Positive Phase 2 Results for Itolizumab in Ulcerative Colitis, Shares Surge

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis
EQ

Business Wire

2 months ago

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

US Penny Stocks To Watch In January 2025
EQ

Simply Wall St.

3 months ago

US Penny Stocks To Watch In January 2025

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates
EQ

Business Wire

5 months ago

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Equillium to Present at the Stifel Healthcare Conference
EQ

Business Wire

5 months ago

Equillium to Present at the Stifel Healthcare Conference

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer
EQ

Business Wire

5 months ago

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth
EQ

Zacks

5 months ago

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

EQ

MT Newswires

5 months ago

Sector Update: Health Care Stocks Softer Late Afternoon

EQ

MT Newswires

5 months ago

Top Midday Decliners

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates
EQ

Zacks

5 months ago

Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue Estimates

Equillium Maintains Rights to Itolizumab Following Ono Partnership
EQ

Business Wire

5 months ago

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Alto Ingredients And 2 Other US Penny Stocks To Watch Closely
EQ

Simply Wall St.

5 months ago

Alto Ingredients And 2 Other US Penny Stocks To Watch Closely

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer
EQ

Business Wire

6 months ago

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy
EQ

Pharmaceutical Technology

7 months ago

Equillium collaborates with Vivtex for oral formulation of autoimmune therapy

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit
EQ

Business Wire

7 months ago

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
EQ

Business Wire

7 months ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
EQ

Business Wire

7 months ago

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

Equillium Second Quarter 2024 Earnings: Beats Expectations
EQ

Simply Wall St.

8 months ago

Equillium Second Quarter 2024 Earnings: Beats Expectations

Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates
EQ

Zacks

8 months ago

Equillium, Inc. (EQ) Beats Q2 Earnings and Revenue Estimates

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights
EQ

Business Wire

8 months ago

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
EQ

Business Wire

8 months ago

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
EQ

Business Wire

8 months ago

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

Equillium to Participate in Upcoming Investor Conferences
EQ

Business Wire

9 months ago

Equillium to Participate in Upcoming Investor Conferences

Equillium to be included in the Russell Microcap® Index
EQ

Business Wire

10 months ago

Equillium to be included in the Russell Microcap® Index

Better AI Stock: Palantir vs. Snowflake
EQ

Motley Fool

10 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?
EQ

Motley Fool

10 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BigBear.ai Stock: Buy, Sell, or Hold?
EQ

Motley Fool

10 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'
EQ

AFP

10 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?
EQ

Motley Fool

10 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp
EQ

GuruFocus.com

10 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...
EQ

GuruFocus.com

10 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)
EQ

Simply Wall St.

10 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
EQ

Business Wire

10 months ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata
EQ

Business Wire

10 months ago

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

Equillium to Present at the Jefferies Global Healthcare Conference
EQ

Business Wire

10 months ago

Equillium to Present at the Jefferies Global Healthcare Conference

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
EQ

Business Wire

a year ago

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
EQ

Zacks

a year ago

Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
EQ

Business Wire

a year ago

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
EQ

Business Wire

a year ago

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate
EQ

Simply Wall St.

a year ago

We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
EQ

Business Wire

a year ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 Stocks That More Than Doubled in Q1 With More Gains Ahead
EQ

Zacks

a year ago

5 Stocks That More Than Doubled in Q1 With More Gains Ahead

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
EQ

Business Wire

a year ago

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates
EQ

Zacks

a year ago

Equillium, Inc. (EQ) Reports Q4 Loss, Tops Revenue Estimates

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
EQ

Business Wire

a year ago

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
EQ

Business Wire

a year ago

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference

Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20%
EQ

Simply Wall St.

a year ago

Individual investors account for 41% of Equillium, Inc.'s (NASDAQ:EQ) ownership, while insiders account for 20%

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark
EQ

Zacks

a year ago

The Zacks Analyst Blog Highlights Janux Therapeutics, SoundHound, Root, Equillium and CleanSpark

5 Stocks That More Than Doubled in February
EQ

Zacks

a year ago

5 Stocks That More Than Doubled in February

5 Top-Ranked Stocks That Have More Than Doubled Year to Date
EQ

Zacks

a year ago

5 Top-Ranked Stocks That Have More Than Doubled Year to Date

Even after rising 85% this past week, Equillium (NASDAQ:EQ) shareholders are still down 85% over the past three years
EQ

Simply Wall St.

a year ago

Even after rising 85% this past week, Equillium (NASDAQ:EQ) shareholders are still down 85% over the past three years

15 Cash-Rich Penny Stocks Hedge Funds Are Buying
EQ

Insider Monkey

a year ago

15 Cash-Rich Penny Stocks Hedge Funds Are Buying

EQ

Associated Press Finance

a year ago

Territorial Bancorp: Q4 Earnings Snapshot

Territorial Bancorp Inc. Declares Dividend
EQ

GlobeNewswire

a year ago

Territorial Bancorp Inc. Declares Dividend

Optex Systems Announces Acquisition of Speedtracker
EQ

ACCESSWIRE

a year ago

Optex Systems Announces Acquisition of Speedtracker

EQ

Business Wire

a year ago

Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd
EQ

GlobeNewswire

a year ago

Vision Sensing Acquisition Corp. Announces Definitive Agreement and Plan of Merger with Mediforum Co., Ltd

EQ

Business Wire

a year ago

Coya Therapeutics Announces Pipeline Expansion of COYA 302 to Include Frontotemporal Dementia and Parkinson’s Disease in Addition to Amyotrophic Lateral Sclerosis

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
EQ

Business Wire

a year ago

DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing
EQ

PR Newswire

a year ago

DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing

Investors in Barnes & Noble Education (NYSE:BNED) from five years ago are still down 65%, even after 19% gain this past week
EQ

Simply Wall St.

a year ago

Investors in Barnes & Noble Education (NYSE:BNED) from five years ago are still down 65%, even after 19% gain this past week

Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation
EQ

GlobeNewswire

a year ago

Gorilla Technology Group’s AI Solution Assists London’s Metropolitan Police Secure Successful Convictions in Complex Homicide Investigation

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones
EQ

GlobeNewswire

a year ago

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference
EQ

PR Newswire

a year ago

Karyopharm to Present at 42nd Annual J.P. Morgan Healthcare Conference

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections
EQ

GlobeNewswire

a year ago

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Web3 Winners: 3 Stocks to Invest in the Decentralized Web
EQ

InvestorPlace

a year ago

Web3 Winners: 3 Stocks to Invest in the Decentralized Web

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
EQ

GlobeNewswire

a year ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

5 Top Energy Growth Stocks That You Need to Buy for 2024
EQ

Zacks

a year ago

5 Top Energy Growth Stocks That You Need to Buy for 2024

EQ

GlobeNewswire

a year ago

NSTS Bancorp Announces Balance Sheet Repositioning

EQ

GlobeNewswire

a year ago

NSTS Bancorp Announces Authorization of Stock Repurchase Program

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
EQ

Business Wire

a year ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

3 AI Stocks I Wouldn’t Touch With a 10-Foot Pole
EQ

InvestorPlace

a year ago

3 AI Stocks I Wouldn’t Touch With a 10-Foot Pole

EQ

Associated Press Finance

a year ago

Enzo Biochem: Fiscal Q1 Earnings Snapshot

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
EQ

GlobeNewswire

a year ago

ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE

FiscalNote Announces Strategic Commercial Partnership to Accelerate Company’s Global AI Co-pilot Program
EQ

Business Wire

a year ago

FiscalNote Announces Strategic Commercial Partnership to Accelerate Company’s Global AI Co-pilot Program

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
EQ

GlobeNewswire

a year ago

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)

Eagle Bancorp Montana, Inc. (NASDAQ:EBMT) most popular amongst retail investors who own 55% of the shares, institutions hold 38%
EQ

Simply Wall St.

a year ago

Eagle Bancorp Montana, Inc. (NASDAQ:EBMT) most popular amongst retail investors who own 55% of the shares, institutions hold 38%

Outlook Therapeutics® Announces Strategic Organizational Realignment
EQ

GlobeNewswire

a year ago

Outlook Therapeutics® Announces Strategic Organizational Realignment

Globalink Investment Inc. Announces Charter and Trust Agreement Amendments
EQ

GlobeNewswire

a year ago

Globalink Investment Inc. Announces Charter and Trust Agreement Amendments

EQ

Business Wire

a year ago

Usio Announces Strategic Partnership with Leading Benefits Administrator, Genius Avenue

Southwest Gas, SP Plus, and More Stocks See Action From Activist Investors
EQ

Barrons.com

a year ago

Southwest Gas, SP Plus, and More Stocks See Action From Activist Investors

DevvStream and Green Cross International (GCI) to Explore Federal Projects with National Governments Aimed at Advancing Decarbonization Activities
EQ

GlobeNewswire

a year ago

DevvStream and Green Cross International (GCI) to Explore Federal Projects with National Governments Aimed at Advancing Decarbonization Activities

Here's What We Like About Ark Restaurants' (NASDAQ:ARKR) Upcoming Dividend
EQ

Simply Wall St.

a year ago

Here's What We Like About Ark Restaurants' (NASDAQ:ARKR) Upcoming Dividend

RumbleOn Announces Extension of $100 Million Rights Offering Subscription Period
EQ

Business Wire

a year ago

RumbleOn Announces Extension of $100 Million Rights Offering Subscription Period

EQ

Business Wire

a year ago

Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024

EQ Bank Card launches in Québec as Carte Banque EQ
EQ

PR Newswire

a year ago

EQ Bank Card launches in Québec as Carte Banque EQ

EQ

Business Wire

a year ago

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

EQ

Business Wire

a year ago

Skillsoft to Report Third Quarter 2024 Financial Results on December 5th

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
EQ

Business Wire

a year ago

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Share on Social Networks: